ArticleFrontiers in public health2025
Humoral response against COVID-19 in the population of western region of Poland.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Exposure to the SARS-CoV-2 activates two forms of active immunity: natural appearance after infection and vaccine induced immunity. Methods: We have conducted a retrospective analysis the serum concentration of IgG antibodies against SARS-CoV-2 in the population of Poznan University Clinical Hospital (PH) and Miedzyrzecz Hospital (MH) from 2021 to 2023. Results: In the entire study population ( Conclusion: The concentration of anti-SARS-CoV-2 IgG antibodies is significantly higher in individuals over 60 years old compared to those in the 18-35 and 36-60 age groups. The correlations between age and antibody levels were significant but weak, suggesting that age should not be considered the main factor in predicting the immune response after vaccination or COVID-19 infection. Both women and men presented a similar immune responses to SARS-CoV-2 during the pandemic. Additionally, the number of infections within a specific time period influenced the number of individuals tested for anti-SARS-CoV-2 antibodies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.